10 likes | 83 Views
Supplemental Digital Content: S2. *. a. Fluorescent Intensity (% Control). Control Fas Ligand FasFc + Fas Ligand FasFc.
E N D
Supplemental Digital Content: S2 * a Fluorescent Intensity (% Control) Control Fas Ligand FasFc + Fas Ligand FasFc Recombinant human FasFc chimeric protein attenuates Fas ligand induced hyperpermeability in RLMECs. Fas Ligand increases RLMEC permeability compared to untreated control cells (*p < 0.05; n = 6). Fas ligand treated monolayers when pre-treated with FasFc show significant decrease in permeability compared with Fas ligand treated monolayers (a p < 0.05; n = 6). FasFc alone treated group shows no significant change in permeability compared to the untreated control cells.